BACKGROUND: Children with leukemia are at risk of developing life-threatening opportunistic pulmonary infections. The role of bronchoalveolar lavage (BAL) and lung biopsy (BX) in the management of these patients is controversial. In this study, we evaluate the yield and safety of BAL and BX in children with leukemia. PROCEDURE: We reviewed the records of all children with leukemia who underwent either BAL or BX between 1997 and 2007 at the St Jude Children's Research Hospital. RESULTS: A total of 64 patients were included, of whom 35 (55%) had BX and 29 (45%) had BAL. Positive results were obtained in 69% of BAL cohort and in 46% of BX cohort. Both procedures resulted in change in antimicrobial coverage (77% in BX, 83% in BAL). Pulmonary hemorrhage occurred in 2 patients, and transient hypoxia was the most frequent complication. All resolved without negatively impacting the clinical course. CONCLUSIONS: Both BAL and BX are safe and useful in the management of children with leukemia and pulmonary disease.
BACKGROUND:Children with leukemia are at risk of developing life-threatening opportunistic pulmonary infections. The role of bronchoalveolar lavage (BAL) and lung biopsy (BX) in the management of these patients is controversial. In this study, we evaluate the yield and safety of BAL and BX in children with leukemia. PROCEDURE: We reviewed the records of all children with leukemia who underwent either BAL or BX between 1997 and 2007 at the St Jude Children's Research Hospital. RESULTS: A total of 64 patients were included, of whom 35 (55%) had BX and 29 (45%) had BAL. Positive results were obtained in 69% of BAL cohort and in 46% of BX cohort. Both procedures resulted in change in antimicrobial coverage (77% in BX, 83% in BAL). Pulmonary hemorrhage occurred in 2 patients, and transient hypoxia was the most frequent complication. All resolved without negatively impacting the clinical course. CONCLUSIONS: Both BAL and BX are safe and useful in the management of children with leukemia and pulmonary disease.
Authors: Sei Won Kim; Chin Kook Rhee; Hye Sun Kang; Hye Yeon Lee; Ji Young Kang; Seung Joon Kim; Seok Chan Kim; Sook Young Lee; Young Kyoon Kim; Jong Wook Lee Journal: Ann Hematol Date: 2014-07-27 Impact factor: 3.673
Authors: DeepakBabu Chellapandian; Thomas Lehrnbecher; Bob Phillips; Brian T Fisher; Theoklis E Zaoutis; William J Steinbach; Joseph Beyene; Lillian Sung Journal: J Clin Oncol Date: 2015-01-05 Impact factor: 44.544
Authors: María Elena Yuriko Furuya; Jorge Luis Ramírez-Figueroa; Mario H Vargas; Roberto Bernáldez-Ríos; José G Vázquez-Rosales; Alicia Rodríguez-Velasco Journal: J Pediatr Hematol Oncol Date: 2012-11 Impact factor: 1.289
Authors: U Rao; A Piccin; A Malone; K O'Hanlon; F Breatnach; A O'Meara; M McDermott; K Butler; N O'Sullivan; J Russell; A O'Marcaigh; O P Smith Journal: Ir J Med Sci Date: 2012-09-16 Impact factor: 1.568
Authors: Kimberly A Kasow; Erin King; Richard Rochester; Xin Tong; Deo Kumar Srivastava; Edwin M Horwitz; Wing Leung; Paul Woodard; Rupert Handgretinger; Gregory A Hale Journal: Biol Blood Marrow Transplant Date: 2007-05-07 Impact factor: 5.742
Authors: Melissa Quinn; J T Fannin; Joseph Sciasci; Allison Bragg; Patrick K Campbell; Delia Carias; Kristine R Crews; David Gregornik; Sima Jeha; Gabriela Maron; Jennifer L Pauley; Hope D Swanson; Joshua Wolf; William Greene Journal: Antimicrob Agents Chemother Date: 2018-07-27 Impact factor: 5.191
Authors: Ali H Ahmad; Brandon D Brown; Clark R Andersen; Kris M Mahadeo; Demetrios Petropolous; José A Cortes; Shehla Razvi; Mary Katherine Gardner; Linette J Ewing; Rodrigo E Mejia Journal: Front Oncol Date: 2021-12-14 Impact factor: 6.244